Form 8-K - Current report:
SEC Accession No. 0001104659-24-119701
Filing Date
2024-11-15
Accepted
2024-11-15 16:05:32
Documents
15
Period of Report
2024-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2428608d1_8k.htm   iXBRL 8-K 29928
2 EXHIBIT 10.1 tm2428608d1_ex10-1.htm EX-10.1 32142
3 EXHIBIT 10.2 tm2428608d1_ex10-2.htm EX-10.2 31351
  Complete submission text file 0001104659-24-119701.txt   282534

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA armp-20241112.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20241112_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20241112_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2428608d1_8k_htm.xml XML 3547
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 241467823
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)